Literature DB >> 23990589

Does serum albumin and creatinine predict survival of inpatient palliative care patients?

Aye Aung1, Shukri Alqudihy1, Lisa Rybicki1, Alexandra Platt1, Mellar P Davis2.   

Abstract

INTRODUCTION: Low creatinine and albumin are found among the chronically ill patients. This study retrospectively reviewed albumin and creatinine levels for survival in patients upon admission.
METHODS: Records of patients admitted over 2 months were reviewed. Recursive partitioning analysis (RPA) identified cutpoints in albumin and creatinine that predicted survival. Kaplan-Meier survival, Cox proportional hazards, and stepwise Cox analyses identified prognostic factors.
RESULTS: Of 83 patients, 81 were assessable. Variables for worse survival were albumin <3.1 g/dL, creatinine >0.93 mg/dL, and male gender. Albumin by continuous, median, RPA, and tertiles was significant; creatinine by RPA. Hazard ratio for albumin >3.1 was 0.28 (P < .001) and for creatinine >0.91 mg/dL was 1.8 (P = .046). DISCUSSION AND
CONCLUSION: Albumin and creatinine are prognostically important.
© The Author(s) 2013.

Entities:  

Keywords:  albumin; creatinine; palliative; prognosis; retrospective; survival

Mesh:

Substances:

Year:  2013        PMID: 23990589     DOI: 10.1177/1049909113501851

Source DB:  PubMed          Journal:  Am J Hosp Palliat Care        ISSN: 1049-9091            Impact factor:   2.500


  2 in total

1.  Risk factors of organ failure in cholangitis with bacteriobilia.

Authors:  Jae Min Lee; Sang Hyub Lee; Kwang Hyun Chung; Jin Myung Park; Ban Seok Lee; Woo Hyun Paik; Joo Kyung Park; Ji Kon Ryu; Yong-Tae Kim
Journal:  World J Gastroenterol       Date:  2015-06-28       Impact factor: 5.742

2.  Kidney Function Worsening Is Linked to Parenteral-Nutrition-Dependent Survival in Palliative Care Patients.

Authors:  Lea Kum; Alexander Friedrich; Markus Kieler; Elias Meyer; Petar Popov; Paul Kössler; Anna Kitta; Feroniki Adamidis; Raimund Oberle; Eva Katharina Masel; Matthias Unseld
Journal:  Nutrients       Date:  2022-02-11       Impact factor: 5.717

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.